Moxalactam in the treatment of typhoid fever.
Moxalactam therapy was evaluated in 25 patients with typhoid fever. A satisfactory initial response was observed in all cases. Treatment for 3 days resulted in a much higher relapse rate (three of five patients) than did treatment for 5 days (one of nine patients). None of the 11 patients treated fo...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180549/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3532946/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.2.338 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|